Prof Sue-Anne McLachlan
Clinical (Professor)
Department of Medicine
267 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort study
DOI: 10.1097/ms9.00000000000049192026
Journal article
Cancer care in custody: health professional perspectives
DOI: 10.1111/imj.703272021
Journal article
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians.
DOI: 10.1158/1940-6207.capr-20-03692020
Journal article
A randomised phase II trial testing the acceptability and feasibility of a narrative approach to public health communication to increase community engagement with palliative care
DOI: 10.1177/02692163209327662020
Journal article
Community knowledge of and attitudes to palliative care: A descriptive study
DOI: 10.1177/02692163198883712018
Journal article
How should we talk about palliative care, death and dying? A qualitative study exploring perspectives from caregivers of people with advanced cancer
DOI: 10.1177/02692163177465842018
Journal article
Communication about palliative care: A phenomenological study exploring patient views and responses to its discussion
DOI: 10.1177/0269216317735247
RECENT SCHOLARLY WORKS
2026
Journal article
Scope and impact of a First Nations cancer coordinator role: perspectives of multidisciplinary cancer staff
DOI: 10.1007/s00520-026-10351-42026
Journal article
Parity and lactation induce T-cell-mediated breast cancer protection
DOI: 10.1038/s41586-025-09713-52026
Journal article
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
DOI: 10.1200/JCO-25-018282025
Journal article
280P Efficacy and safety of ivosidenib in Australian and South Korean patients with IDH1 mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study
DOI: 10.1016/j.annonc.2025.10.1072025
Journal article
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
DOI: 10.1038/s41591-025-04030-w2025
Journal article
262P EGFR mutations (EGFR ) or ALK rearrangements (ALK ) in the BR31 trial of adjuvant durvalumab (D) v placebo (P)
DOI: 10.1016/j.iotech.2025.1014612025
Journal article
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry
DOI: 10.21037/jgo-2025-1862025
Journal article
2244P Borderline and locally advanced pancreatic cancer: Using real-world data to explore presentation, treatment patterns and outcomes
DOI: 10.1016/j.annonc.2025.08.2861